% | $
Quotes you view appear here for quick access.

Amarantus Bioscience Holdings, Inc Message Board

  • xxthx xxthx Nov 25, 2012 5:18 PM Flag

    Amgen cofounder (60 billion) on AMBS Board (10 million marketcap)

    I like Dr Rubinfelds discussion of the Fundamentals
    IMO remarks like these coming from a man of his stature is ENOUGH SAID

    "I believe in MANF," said Dr. Rubinfeld (Amgen cofounder), "I have reviewed a great number of technologies in my 45 year career in the biopharmaceutical field, and I believe that MANF could be one of the biggest successes that I have ever seen. The fundamental scientific premise of reducing protein misfolding is basic, yet very profound. The data, while early, demonstrates very clearly at the cellular level and in animals that MANF reduces apoptosis, improves cellular function, and restores behavioural deficits in a number of disease models, including Parkinson's, Stroke, Myocardial Infarction and Traumatic Brain Injury. These are all indications with very large markets and clear unmet medical need. I believe that if we are able to further de-risk MANF with positive toxicology studies and early clinical data, the Company's new orphan drug strategy could get MANF to market rather expeditiously. MANF has the commercial potential to become a blockbuster drug.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.034+0.004(+15.25%)Oct 21 3:52 PMEDT